Detalles de la búsqueda
1.
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG.
NPJ Vaccines
; 9(1): 104, 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38858418
2.
Evaluation in mice of cell-free produced CT584 as a Chlamydia vaccine antigen.
bioRxiv
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38895407
3.
Determination of the safety and efficacy of recombinant Chlamydia muridarum MOMP vaccines, formulated with CpG-1826 and 70%, 50%, 30% or 10% concentrations of Montanide ISA-720 VG, to elicit protective immune responses against a C. muridarum respiratory challenge.
Res Sq
; 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38168233
4.
Evaluation of Four Adjuvant Combinations, IVAX-1, IVAX-2, CpG-1826+Montanide ISA 720 VG and CpG-1018+Montanide ISA 720 VG, for Safety and for Their Ability to Elicit Protective Immune Responses in Mice against a Respiratory Challenge with Chlamydia muridarum.
Pathogens
; 12(7)2023 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37513710
5.
The Polymorphic Membrane Protein G Has a Neutral Effect and the Plasmid Glycoprotein 3 an Antagonistic Effect on the Ability of the Major Outer Membrane Protein to Elicit Protective Immune Responses against a Chlamydia muridarum Respiratory Challenge.
Vaccines (Basel)
; 11(3)2023 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992088
Resultados
1 -
5
de 5
1
Próxima >
>>